Literature DB >> 6757224

Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.

T Gotoh, K Nakahara, T Nishiura, M Hashimoto, T Kino, Y Kuroda, M Okuhara, M Kohsaka, H Aoki, H Imanaka.   

Abstract

An interesting immunoactive peptide, FK-156, has been isolated from the fermentation broth of Streptomyces olivaceogriseus sp. nov. and Streptomyces violaceus. The compound was purified by column chromatography with activated carbon, ion exchange Sephadex and cellulose powder. FK-156, obtained as white powder, exhibits a wide variety of immunostimulatory activity in vivo and in vitro with experimental animals. Pretreatment of mice or rats with this peptide protected the animals against lethal infection with Escherichia coli and resulted in prolongation of life span of tumor bearing animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6757224     DOI: 10.7164/antibiotics.35.1286

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

1.  Immunomodulatory and therapeutic properties of FK-565 in mice.

Authors:  J E Talmadge; B Lenz; M Schneider; H Phillips; C Long
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  Immunomodulators isolated from microorganisms.

Authors:  Z Vanĕk; J Matĕjů; E Curdová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

3.  Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.

Authors:  K Ahmed; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.

Authors:  C D Leclerc; F M Audibert; L A Chedid; E J Deriaud; N K Masihi; E Lederer
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Synergism of synthetic acyltripeptide and its analogs with recombinant interferon gamma for activation of antitumor properties of human blood monocytes.

Authors:  S Sone; A Okubo; N Inamura; A Nii; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.

Authors:  S Sone; S Mutsuura; M Ogawara; T Utsugi; E Tsubura
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Structural characteristics of peptidoglycan fragments required to prime mice for induction of anaphylactoid reactions by lipopolysaccharides.

Authors:  H Takada; Y Kawabata; S Kawata; S Kusumoto
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

Review 8.  Translation of peptidoglycan metabolites into immunotherapeutics.

Authors:  Matthew E Griffin; Charles W Hespen; Yen-Chih Wang; Howard C Hang
Journal:  Clin Transl Immunology       Date:  2019-11-29

9.  A facile synthesis of fully protected meso-diaminopimelic acid (DAP) and its application to the preparation of lipophilic N-acyl iE-DAP.

Authors:  Yukako Saito; Yuichi Yoshimura; Hideaki Wakamatsu; Hiroki Takahata
Journal:  Molecules       Date:  2013-01-16       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.